Premium
The Tumor Suppressor Interferon Regulatory Factor 2 Binding Protein 2 Regulates Hippo Pathway in Liver Cancer by a Feedback Loop in Mice
Author(s) -
Feng Xue,
Lu Tiantian,
Li Jinhui,
Yang Ruizeng,
Hu Liqiao,
Ye Yi,
Mao Feifei,
He Lingli,
Xu Jinjin,
Wang Zuoyun,
Liu Yingbin,
Zhang Yonglong,
Ji Hongbin,
Zhao Yun,
Cheng Shuqun,
Tian Wei,
Zhang Lei
Publication year - 2020
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.30961
Subject(s) - hippo signaling pathway , carcinogenesis , biology , transcription factor , suppressor , corepressor , microbiology and biotechnology , cancer research , liver cancer , transcriptional regulation , effector , cancer , repressor , hepatocellular carcinoma , genetics , gene
Background and Aims The conserved Hippo pathway regulates organ size, tissue homeostasis, and tumorigenesis. Interferon regulatory factor 2 binding protein 2 (IRF2BP2) was originally identified as a transcriptional corepressor. However, the association between IRF2BP2 and the Hippo pathway remains largely unknown. In addition, the biological function and regulation mechanism of IRF2BP2 in liver cancer are poorly understood. Approach and Results In this study, we uncovered the clinical significance of IRF2BP2 in suppressing hepatocellular carcinogenesis. We showed that IRF2BP2, a direct target repressed by the Yes‐associated protein (YAP)/TEA domain transcription factor 4 (TEAD4) transcriptional complex, inhibited YAP activity through a feedback loop. IRF2BP2 stabilized vestigial‐like family member 4 (VGLL4) and further enhanced VGLL4’s inhibitory function on YAP. Moreover, liver‐specific IRF2BP2 overexpression suppressed tumor formation induced by Hippo pathway inactivation. Conclusions These results revealed the important role of IRF2BP2 in repressing liver cancer progression and highlighted a feedback loop underlying the Hippo pathway in organ‐size control and tumorigenesis.